|
|
|
| Drug discovery is shifting from traditional hit identification toward data-driven strategies that extract deeper insight from large-scale screening datasets. Advances in DNA-encoded library (DEL) screening, computational tools, and machine learning are helping teams make more informed decisions in early-stage drug development. Access this brand-new Drug Discovery Online content collection for an under-the-hood look at modern approaches to turning large discovery datasets into actionable insight. |
|
|
|
|
|
| Antibody-Drug Conjugates – Catalysts For Chemistry | White Paper | Curia | Review the complexities of developing linkers – chemical moieties which attach a drug payload to an antibody – and considerations when identifying a CRO for ADC research and development. |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | A good CDMO – differentiated from a not-as-good CDMO – dialogues productively with customers, and a great starting point is when discussing development plans that should then lead to manufacturing opportunities. What should these conversations entail? Outsourcing pro David Grote speaks to Chief Editor Louis Garguilo on his "discussion philosophy." | |
|
|
U.S. Pharma Tariffs And MFN Become Law After April 2 Update | By Mathini Ilancheran, R&D, Beroe Inc. | Beginning July 31, 2026, a U.S. pharmaceutical tariff will apply to patented products and their APIs, beginning with large companies. Beroe Inc.'s Mathini Ilancheran breaks down the tariff's impact, explores its risks, and proposes five procurement strategies to addressing them. |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
| Early-Phase Injectable Formulation Development | White Paper | Thermo Fisher Scientific | Discover how expert-driven strategies and data-centric tools can help you overcome formulation challenges and accelerate the development of stable, high-performance injectable therapeutics. |
|
|
|
|
|
|
|
| Join Outsourced Pharm Live’s Jeff Buguliskis and panelists on May 11 at 11 AM ET for ADC Outsourcing: Plan Smart Now or Suffer Later. Registration for this virtual event is free thanks to sponsor Lonza. |
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
